April 6, 2011

Forbes

Forbes Midas List

Mike Carusi is featured on the 2011 Forbes Midas list of "Tech's Top Investors."

Healthcare investor is single-handedly proving life science investments that are not just a charity case. In the first three months of this year two portfolio companies backed by Carusi--Ardian (hypertension devices) and Plexxikon (cancer therapies)--sold for more than $1.6 billion. Carusi reaped 10x his early investment when Plexxikon sold to Japan’s Daiichi Sankyo for $805 million (plus a $130 million earn-out). Ardian’s sale to Medtronic for $800 million in cash netted ATV a 15x return on investment. Looks for early-stage opportunities in disruptive pharma and medical device companies.